Grant Application Submission Clause Samples

The Grant Application Submission clause outlines the requirements and procedures for submitting an application to be considered for a grant. It typically specifies the necessary documentation, deadlines, and format in which applications must be provided, and may detail the method of submission, such as through an online portal or by mail. This clause ensures that all applicants follow a standardized process, which helps the grantor efficiently review and evaluate applications while minimizing errors or omissions.
Grant Application Submission. Following approval by the ARB or HPB and issuance of the appropriate review Certificate, as required, the Grant application and all attachments may be submitted to the Of the Grants Coordinator for formal consideration of funding.
Grant Application Submission. Following approval by the ARB or HPB and issuance of the appropriate review Certificate, as required, the Grant application and all attachments may be submitted to the DFP Program Manager for formal consideration of funding.
Grant Application Submission. The Grant application and all attachments are submitted to the Facade Program Coordinator for formal consideration of funding. A $50 non-refundable application fee is due with application submission. The application fee offsets the cost of background checks and other necessary due diligence performed by the Façade Program Coordinator.
Grant Application Submission. The Grant Application submission must be submitted electronically, via email, in Adobe Acrobat (.pdf) format (except the Business Case Application Form must remain in the original Excel format) by the submission deadline provided below and must include the full legal name, full contact information and address of the Applicant. The email subject line must include the following: The complete Grant Application should be in one (1) email, including attachments, and should not be larger than 25MB to facilitate receipt by the Province. If multiple emails are required to accommodate attachment sizes, the emails should provide clear instructions on how the Grant Application is to be integrated (e.g., 1 of 3, 2 of 3, 3 of 3). The official time and date of receipt of the Grant Application will be determined by the email received time as recorded by the Government of Alberta’s email server. Applicants should be aware that, prior to such electronic delivery, incoming emails are subject to consistency checks and antivirus scans, processes which can take several minutes or longer to complete. The Province will not be responsible for failures (technical or otherwise) that may result in a Grant Application not being received prior to the Grant Application Closing Date and Time. If the Grant Application cannot be opened after reasonable efforts are made by the Province, the Grant Application will be rejected. The Grant Application should be secured against accidental modification by the Province (with the exception of the Business Case Application Form, which must remain in the original Excel format), and should have the ability to search and print the document in its entirety. Grant Applications must be received on or before 4:30 pm MST Friday, January 6, 2023 by Alberta Health at the following email address: Classification: Public Applicants are responsible for late deliveries of Grant Applications. Alberta Health reserves the right to reject any Grant Application received after the deadline or submitted in a manner other than as described in this document. Faxed Grant Applications will not be accepted. Alberta Health will acknowledge receipt of Grant Applications; the acknowledgment of receipt does not constitute an acknowledgement by Alberta Health that the Grant Application is accurate, complete, or complies with the process.
Grant Application Submission. CITY shall be responsible for final submission of grant application with original physical signature(s), if required.

Related to Grant Application Submission

  • Application Submission Submissions of a rental application does not guarantee approval or acceptance. It does not bind us to accept the application or to sign a Lease contact.

  • New Application for Licensure Any time after the three-month period has lapsed from the Effective Date of this Agreement and Respondent has paid the Administrative Penalty set forth in Section III, Paragraph 1 of this Order, Respondent may apply for a new mortgage loan originator license or, as applicable, petition for the reinstatement of an MLO Activity Endorsement in any or all of the Participating States with the understanding that each State Mortgage Regulator reserves the rights to fully investigate such application for licensure or petition for reinstatement of an MLO Activity Endorsement and may either approve or deny such application or petition pursuant to the normal process for such licensing or endorsement investigations. No license application or petition described in this paragraph will be denied solely based on the facts, circumstances, or consensual resolution provided for in this Agreement. Respondent further agrees that Respondent must satisfy the Administrative Penalty provision prior to submitting an application for a new mortgage loan originator license or, as applicable, petition for the reinstatement of an MLO Activity Endorsement.

  • Claims Submission We will submit your claims and assist you in any way we reasonably can to help get your claims paid. Your insurance company may need you to supply certain information directly. It is your responsibility to comply with their request. Please be aware that the balance of your claim is your responsibility whether or not your insurance company pays your claim. Your insurance benefit is a contract between you and your insurance company; we are not party to that contract.

  • Updated Information Submission by Developer The updated information submission by the Developer, including manufacturer information, shall occur no later than one hundred eighty (180) Calendar Days prior to the Trial Operation. Developer shall submit a completed copy of the Large Generating Facility data requirements contained in Appendix 1 to the Standard Large Facility Interconnection Procedures. It shall also include any additional information provided to Connecting Transmission Owner for the Interconnection Facilities Study. Information in this submission shall be the most current Large Generating Facility design or expected performance data. Information submitted for stability models shall be compatible with NYISO standard models. If there is no compatible model, the Developer will work with a consultant mutually agreed to by the Parties to develop and supply a standard model and associated information. If the Developer’s data is different from what was originally provided to Connecting Transmission Owner and NYISO pursuant to an Interconnection Study Agreement among Connecting Transmission Owner, NYISO and Developer and this difference may be reasonably expected to affect the other Parties’ facilities or the New York State Transmission System, but does not require the submission of a new Interconnection Request, then NYISO will conduct appropriate studies to determine the impact on the New York State Transmission System based on the actual data submitted pursuant to this Article 24.3. Such studies will provide an estimate of any additional modifications to the New York State Transmission System, Connecting Transmission Owner’s Attachment Facilities or System Upgrade Facilities or System Deliverability Upgrades based on the actual data and a good faith estimate of the costs thereof. The Developer shall not begin Trial Operation until such studies are completed. The Developer shall be responsible for the cost of any modifications required by the actual data, including the cost of any required studies.

  • How to File an Appeal of a Prescription Drug Denial For denials of a prescription drug claim based on our determination that the service was not medically necessary or appropriate, or that the service was experimental or investigational, you may request an appeal without first submitting a request for reconsideration. You or your physician may file a written or verbal prescription drug appeal with our pharmacy benefits manager (PBM). The prescription drug appeal must be submitted to us within one hundred and eighty (180) calendar days of the initial determination letter. You will receive written notification of our determination within thirty (30) calendar days from the receipt of your appeal. Your appeal may require immediate action if a delay in treatment could seriously jeopardize your health or your ability to regain maximum function, or would cause you severe pain. To request an expedited appeal of a denial related to services that have not yet been rendered (a preauthorization review) or for on-going services (a concurrent review), you or your healthcare provider should call: • our Grievance and Appeals Unit; or • our pharmacy benefits manager for a prescription drug appeal. Please see Section 9 for contact information. You will be notified of our decision no later than seventy-two (72) hours after our receipt of the request. You may not request an expedited review of covered healthcare services already received.